Back to Selection     Print       Date : 30 Nov 2025
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-99
Corpus(Cr.) 1126.0 Latest NAV 268.6422 As on 29-01-2026
Equity(%) 98.74 52 Week High 299.714
Debt(%) 1.26 52 Week Low 247.991
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.26
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 29.95%
Top 10 Holdings 47.10%
Top 25 Holdings 80.19%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 76.1
Healthcare 22.64
Cash 1.25
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.60
PE Ratio 0.00
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 9.76
Ajanta Pharma Limited 6.48
Lupin Limited 5.91
Glenmark Pharmaceuticals Limited 4.06
Dr Reddys Laboratories Limited 3.74
Gland Pharma Limited 3.46
Apollo Hospitals Enterprise Limited 3.45
Alkem Laboratories Limited 3.43
Procter & Gamble Health Limited 3.41
Cipla Limited 3.40
EQ- JUPITER LIFE LINE HOSPITALS LTD 2.98
DIVI LABORATORIES LTD. 2.88
Aurobindo Pharma Limited 2.72
Eris Lifesciences Limited 2.49
Max Healthcare Institute Limited 2.48
Fortis Health Care Ltd 2.29
Caplin Point Laboratories Limited 2.22
Krishna Inst of Medical Sciences Ltd. 2.15
IPCA Laboratories Limited 2.03
Cohance Lifesciences Limited 1.93
EQ- GLOBAL HEALTH LTD. 1.88
Sai Life Sciences Limited 1.80
Aster DM Healthcare Limited 1.80
SEQUENT SCIENTIFIC LTD 1.73
Pfizer Limited 1.71

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-4.46% -8.41% -10.18% 0.84%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-1.95% -2.33% 2.82% 11.06%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-5.17% -7.63% -8.31% 2.09%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
12.30% 22.55% 14.60% 11.21%
 
 
9.44% 14.31% 14.62% 14.28%
 
 
11.76% 21.05% 14.74% 8.72%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 15.79% 1.2243 10.4218% 43.8430 0.1614
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) 13.6148% 0.0002 0.3173 13.8462 0.9050
 
Back to Selection